Virtual Symposium- Challenges and Advances in Long-Term Obesity Management: Interpreting and Applying the Evidence to Patient Care
Nearly 40% of adults in the United States are obese: a number that is expected to rise in the near future.  The impacts of obesity are profound, both in terms of increasing cardiometabolic risk as well as exacerbating morbidity and mortality from existing cardiometabolic conditions.  During this
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Webcast: Cardiorenal Risk Reduction With Novel Non-Steroidal MRAS - Advances and Expert Perspectives
During this activity, experts will discuss recent data about the cardiovascular and renal benefits with novel non-steroidal MRAs in patients with diabetic kidney disease (DKD), including the FIGARO-DKD trial and FIDELITY analysis, as well as their clinical practice implications.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
CMHC Masterclass On Demand: Frontiers in Interventional Cardiology
This masterclass is designed to explore the latest advances about the most pertinent domains in interventional cardiology.
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
At the Frontiers of Care: The Emerging Role of CGM in Improving Glycemic Control and Outcomes During Pregnancy
Pregnant women with diabetes often require strict glycemic control in order to reduce the possibility of both immediate and long-term maternal and fetal complications, including macrosomia, large or small for gestational age, C-section, neonatal hyperglycemia, and many more
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
The Emerging Role of CGM for Patients with Type 2 Diabetes: Rationale, Evidence, and Practice Pearls for Integration
Continuous glucose monitoring (CGM) has emerged as a clinically useful tool for the management of patients with type 2 diabetes, as it provides real-time data to better guide glycemic variability, improve glycemic control, as well as reduce the risk of hypoglycemia and hospitalizations.
Category
  • CMHC
Format
  • Video
Credits
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
CMHC Spring 2022 On Demand
The 2022 CMHC Spring recorded sessions highlight the latest updates in CKD, heart failure, hypertension, type 2 diabetes, dyslipidemia, lifestyle management, obesity, and cardiovascular health, as well as translate cutting-edge medical research into practical, clinical strategies for preventing,
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Virtual Symposium - Assessing the Role of TAVR Across the Risk Continuum: Emerging Evidence, Evolving Guidance, and Expert Perspectives
Aortic stenosis (AS) is a fatal disease if not treated promptly, especially in the older population.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Virtual Symposium: CGM - Going Beyond HbA1c to Optimize and Individualize T2D Management
Measuring HbA1c has been the method of choice to assess glucose control; however, it does not reflect potential glucose excursions leading to hypoglycemia or postprandial hyperglycemia, which increase the risk of long-term complications, as well as overall glycemic variability.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Webcast: Challenging Cases in Patients with Iron Deficiency and Heart Failure
Addressing iron deficiency (ID) in patients with heart failure (HF) has become an important aspect of optimizing guideline-directed care in HF, as outlined by recent evidence and updated guidelines.
Category
  • CMHC
Format
  • Video
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
Webcast: Advances in Screening, Diagnosis, and Treatment of Iron Deficiency in Heart Failure Patients
Iron deficiency (ID) with or without anemia is a common and important comorbidity in patients with heart failure (HF), and it can have significant impacts on morbidity and mortality.  Despite this burden, the diagnosis and assessment of ID is not widely sought by clinicians that see patients with
Category
  • CMHC
Format
  • Video
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation

Pages